NO20052991D0 - Kinazolinforbindelser. - Google Patents
Kinazolinforbindelser.Info
- Publication number
- NO20052991D0 NO20052991D0 NO20052991A NO20052991A NO20052991D0 NO 20052991 D0 NO20052991 D0 NO 20052991D0 NO 20052991 A NO20052991 A NO 20052991A NO 20052991 A NO20052991 A NO 20052991A NO 20052991 D0 NO20052991 D0 NO 20052991D0
- Authority
- NO
- Norway
- Prior art keywords
- quinazoline
- Prior art date
Links
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02293239 | 2002-12-24 | ||
PCT/GB2003/005636 WO2004058752A1 (en) | 2002-12-24 | 2003-12-22 | Quinazoline compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20052991D0 true NO20052991D0 (no) | 2005-06-17 |
NO20052991L NO20052991L (no) | 2005-07-19 |
Family
ID=32668916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20052991A NO20052991L (no) | 2002-12-24 | 2005-06-17 | Kinazolinforbindelser. |
Country Status (12)
Country | Link |
---|---|
US (1) | US7407946B2 (no) |
EP (1) | EP1575946A1 (no) |
JP (1) | JP2006516138A (no) |
KR (1) | KR20050087863A (no) |
CN (1) | CN1753889A (no) |
AU (1) | AU2003290322A1 (no) |
BR (1) | BR0317680A (no) |
CA (1) | CA2508921A1 (no) |
MX (1) | MXPA05006920A (no) |
NO (1) | NO20052991L (no) |
WO (1) | WO2004058752A1 (no) |
ZA (1) | ZA200504828B (no) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY136174A (en) * | 2002-12-24 | 2008-08-29 | Astrazeneca Ab | Phosphonooxy quinazoline derivatives and their pharmaceutical use |
DE602004012725T2 (de) * | 2003-04-16 | 2009-04-16 | Astrazeneca Ab | Quinazolin-derivate für die behandling von krebs |
ES2308182T3 (es) * | 2003-06-02 | 2008-12-01 | Astrazeneca Ab | Derivadosde (3-((quinazolin-4-il)amino)-1h-pirazol-1-il)acetamida y compuestos relacionados como inhibidores de quinasas aurora para el tratamiento de enfermedades proliferativas tales como el cancer. |
WO2005061519A1 (en) | 2003-12-19 | 2005-07-07 | Takeda San Diego, Inc. | Kinase inhibitors |
EP1778669A2 (en) | 2004-08-18 | 2007-05-02 | Takeda San Diego, Inc. | Kinase inhibitors |
MX2007004403A (es) | 2004-10-12 | 2007-04-27 | Astrazeneca Ab | Derivados de quinazolina. |
WO2006044687A2 (en) | 2004-10-15 | 2006-04-27 | Takeda San Diego, Inc. | Kinase inhibitors |
US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
EP1785420A1 (en) * | 2005-11-14 | 2007-05-16 | 4Sc Ag | Thiazole analogues and uses thereof |
WO2007099335A1 (en) * | 2006-03-02 | 2007-09-07 | Astrazeneca Ab | Quinoline derivatives for treating cancer |
UY30183A1 (es) | 2006-03-02 | 2007-10-31 | Astrazeneca Ab | Derivados de quinolina |
US20090076075A1 (en) * | 2006-03-02 | 2009-03-19 | Frederic Henri Jung | Quinoline derivatives |
WO2007113548A1 (en) * | 2006-04-06 | 2007-10-11 | Astrazeneca Ab | Naphthyridine derivatives |
US20070258976A1 (en) * | 2006-05-04 | 2007-11-08 | Ward Keith W | Combination Therapy for Diseases Involving Angiogenesis |
GB0609617D0 (en) | 2006-05-16 | 2006-06-21 | Astrazeneca Ab | Process & intermediate |
SG175609A1 (en) | 2006-10-09 | 2011-11-28 | Takeda Pharmaceutical | Kinase inhibitors |
EP2149565A1 (de) | 2008-07-24 | 2010-02-03 | Bayer Schering Pharma AG | Sulfonsubstituierte Chinazolinderivate als Immunmodulatoren zur Behandlung von enzündlichen und allergischen Erkrankungen |
EP2558461B1 (en) | 2010-04-14 | 2015-12-02 | Bristol-Myers Squibb Company | Novel glucokinase activators and methods of using same |
US10222377B2 (en) * | 2011-01-21 | 2019-03-05 | Basilea Pharmaceutica Ag | Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles |
EP2956138B1 (en) | 2013-02-15 | 2022-06-22 | Kala Pharmaceuticals, Inc. | Therapeutic compounds and uses thereof |
KR102277833B1 (ko) | 2013-02-20 | 2021-07-14 | 칼라 파마슈티컬스, 인크. | 치료 화합물 및 그의 용도 |
US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
NZ719185A (en) | 2013-11-01 | 2017-11-24 | Kala Pharmaceuticals Inc | Crystalline forms of therapeutic compounds and uses thereof |
AU2017324716B2 (en) | 2016-09-08 | 2020-08-13 | KALA BIO, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
CA3036336A1 (en) | 2016-09-08 | 2018-03-15 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
AU2017324251A1 (en) | 2016-09-08 | 2019-03-21 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EE200200119A (et) | 1999-09-21 | 2003-04-15 | Astrazeneca Ab | Kinasoliini derivaadid ja nende kasutamine ravimitena |
GB9922171D0 (en) | 1999-09-21 | 1999-11-17 | Zeneca Ltd | Chemical compounds |
EE200200715A (et) | 2000-06-28 | 2004-08-16 | Astrazeneca Ab | Asendatud kinasoliini derivaadid ja nende kasutamine inhibiitoritena |
EP1408980A4 (en) | 2001-06-21 | 2004-10-20 | Ariad Pharma Inc | NEW QUINAZOLINES AND THEIR USE |
MY136174A (en) * | 2002-12-24 | 2008-08-29 | Astrazeneca Ab | Phosphonooxy quinazoline derivatives and their pharmaceutical use |
US20060058325A1 (en) * | 2002-12-24 | 2006-03-16 | Astrazeneca Ab | Therapeutic quniazoline derivatives |
-
2003
- 2003-12-22 EP EP03782681A patent/EP1575946A1/en not_active Withdrawn
- 2003-12-22 CN CNA2003801098990A patent/CN1753889A/zh active Pending
- 2003-12-22 KR KR1020057012019A patent/KR20050087863A/ko not_active Application Discontinuation
- 2003-12-22 CA CA002508921A patent/CA2508921A1/en not_active Abandoned
- 2003-12-22 BR BR0317680-0A patent/BR0317680A/pt not_active Application Discontinuation
- 2003-12-22 WO PCT/GB2003/005636 patent/WO2004058752A1/en active Application Filing
- 2003-12-22 JP JP2004563353A patent/JP2006516138A/ja active Pending
- 2003-12-22 US US10/539,481 patent/US7407946B2/en not_active Expired - Fee Related
- 2003-12-22 AU AU2003290322A patent/AU2003290322A1/en not_active Abandoned
- 2003-12-22 MX MXPA05006920A patent/MXPA05006920A/es not_active Application Discontinuation
-
2005
- 2005-06-13 ZA ZA200504828A patent/ZA200504828B/en unknown
- 2005-06-17 NO NO20052991A patent/NO20052991L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2006516138A (ja) | 2006-06-22 |
WO2004058752A1 (en) | 2004-07-15 |
US7407946B2 (en) | 2008-08-05 |
EP1575946A1 (en) | 2005-09-21 |
BR0317680A (pt) | 2005-11-29 |
KR20050087863A (ko) | 2005-08-31 |
CA2508921A1 (en) | 2004-07-15 |
CN1753889A (zh) | 2006-03-29 |
NO20052991L (no) | 2005-07-19 |
MXPA05006920A (es) | 2006-02-10 |
AU2003290322A1 (en) | 2004-07-22 |
ZA200504828B (en) | 2008-02-27 |
US20060058523A1 (en) | 2006-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1474420T3 (da) | Quinazolinforbindelser | |
NO20052991D0 (no) | Kinazolinforbindelser. | |
DK1667992T3 (da) | Quinazolinderivater | |
NO20053248D0 (no) | Kerosenblanding. | |
DE60305332D1 (de) | IMIDAZOi1,2-AöPYRIDINE | |
NO20052248D0 (no) | Svivelstykkesystem. | |
NO20051500D0 (no) | Substituerte heterocyklylpyrimidiner. | |
ITMI20032170A1 (it) | Tagliacimosse. | |
NO20051497D0 (no) | Beta-laktamaseinhibitorprodrug. | |
ITMI20030916A1 (it) | Lancetta. | |
ES1052590Y (es) | Quiosco-consigna. | |
ES1052029Y (es) | Balin-proyectil. | |
ES1052938Y (es) | Cantonera. | |
ES1052654Y (es) | Cubitera. | |
ES1051605Y (es) | Cromo-puzzle. | |
ES1052011Y (es) | Espetero. | |
ES1052945Y (es) | Contraventana. | |
ES1051703Y (es) | Potera. | |
ES1051110Y (es) | Caja-palet. | |
ITRM20020034A1 (it) | Fiocchettatrice. | |
ITTO20020864A1 (it) | Salvapolsino. | |
ITRE20020088A1 (it) | Parcheggiafacile. | |
ITRE20020089A1 (it) | Apparecchiatutto. | |
ITRM20020151U1 (it) | Mobile-letto. | |
ITRM20020327A0 (it) | Dnaser. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |